CVA
XRAY icon

Ceredex Value Advisors’s Dentsply Sirona XRAY Stock Holding History

Ceredex Value Advisors’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-458,700
Closed -$15.7M – 175
2023
Q3 		$15.7M Buy
458,700
+32,400
+8% +$1.23M 0.28% 88
2023
Q2 		$17.1M Sell
426,300
-170,465
-29% -$6.78M 0.28% 83
2023
Q1 		$23.5M Buy
596,765
+27,900
+5% +$1.02M 0.37% 87
2022
Q4 		$18.2M Buy
+568,865
New +$17.1M 0.28% 92
2022
Q2 		– Sell
-3,804,203
Closed -$188M – 165
2022
Q1 		$188M Buy
3,804,203
+572,840
+18% +$30.3M 2.26% 8
2021
Q4 		$181M Buy
3,231,363
+1,926,113
+148% +$106M 1.95% 11
2021
Q3 		$75.9M Buy
+1,305,250
New +$80.5M 0.86% 43

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $588M AUM 6.93% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Ceredex Value Advisors's XRAY Position: Q4 2023 in Review

Ceredex Value Advisors sold out of Dentsply Sirona (XRAY) in Q4 2023, closing a stake of 458,700 shares — an estimated $15.7M sold.

Ceredex Value Advisors first reported a position in XRAY in Q3 2021 and held it in 7 quarters. The position peaked at $188M in Q1 2022. 417 funds tracked by Wall St. Rank hold XRAY as of Q4 2023.

  • Ceredex Value Advisors reported no remaining Dentsply Sirona position as of Q4 2023 after selling out during the quarter.
  • Ceredex Value Advisors sold 458,700 Dentsply Sirona shares in Q4 2023, an estimated $15.7M.
  • Ceredex Value Advisors first reported a position in Dentsply Sirona in Q3 2021 and held it in 7 quarters.
  • Ceredex Value Advisors's Dentsply Sirona position peaked at $188M in Q1 2022.
  • 417 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2023.

Based on Ceredex Value Advisors's 13F filing for Q4 2023, filed 25 Jan 2024.